Posts by Nicholas Alan Clayton

Latest

TCGX Acquisition Corp. II (TCXB) Prices $100M IPO

TCGX Acquisition Corp. II (NASDAQ:TCXB) announced the pricing of its $100 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol "TCXB" on Friday, October 16, 2026. More

Nicholas Alan Clayton·Oct 15

Top 3 SPAC Targets – Insurance

In the last iteration of this column, SPACInsider took a look at some industries and targets that should be high on a SPAC team’s list, especially should inflation and interest rate pressures force a renewed focus on cash-generating targets. More

Nicholas Alan Clayton·Oct 15

Pyrophyte II (PAII) to Combine with Sakuu Corporation in $682M Deal

Pyrophyte II (NYSE:PAII) has entered into a definitive agreement to combine with manufacturing firm Sakuu at a pro forma enterprise value of $682.3 million. San Jose, California-based Sakuu is developing manufacturing lines for more efficiently producing battery materials for a number of industries. More

Nicholas Alan Clayton·Oct 15

Morning SPAC News Roundup: October 15, 2026

In a first for SPACs this week, two teams released the results from shareholder votes, in which zero shares were redeemed in connection with either of them. More

Nicholas Alan Clayton·Oct 15

Morning SPAC News Roundup: October 14, 2026

In the latest move to allow subscribers to leverage AI to work with SPACInsider data, SPACInsider now has two MCP plugins available on both ChatGPT and Claude. More

Nicholas Alan Clayton·Oct 14

Frazier Life Sciences Acquisition Corp. II (FLSC) Prices $75M IPO

Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC) announced the pricing of its $75 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol "FLSC" on Wednesday, October 14, 2026. More

Nicholas Alan Clayton·Oct 13

New SPAC: Apex Treasury Corp II (APTTU) Files for $250M IPO

Apex Treasury Corp II (NASDAQ:APTTU) has filed for a $250 million SPAC to look at AI targets as well as a number of other hot sectors. The new SPAC is offering investors a 1/3 warrant in each unit, but it will not be overfunding its trust or shortening its transaction deadline from 24 months. More

Nicholas Alan Clayton·Oct 13

Horizon Space I (HSPOF) to Combine with ArcheNova Biotech in $2Bn Deal

Horizon Space I (OTC:HSPOF) has entered into a definitive agreement to combine with ArcheNova Biotech at a $2 billion valuation. ArcheNova is developing a series of drug candidates and offering its own discovery platform to other firms in the biotech space. More

Nicholas Alan Clayton·Oct 13

Morning SPAC News Roundup: October 13, 2026

After an EDGAR holiday, the rate of filings has not been the torrent that one might have expected, although it did bring one more new business combination bringing October's total to eight and the year's tally to 83. More

Nicholas Alan Clayton·Oct 13

Quantumsphere (QUMS) to Combine with Fortune Favor Global in $600M Deal

Quantumsphere (NASDAQ:QUMS) has entered into a plan of merger with medical firm Fortune Favor Global for $600 million in pre-money equity consideration. Fortune Favor Global provides consulting services and products for the medical cold chain transportation sector. More

Nicholas Alan Clayton·Oct 12